MP Healthcare Venture Management is a venture capital firm investing in biotechnology and healthcare companies that is headquartered in Boston, Massachusetts and was founded in 2006 as a venture capital arm of Mitsubishi Tanabe Pharma Corp.
MP Healthcare Venture Management has made 29 investments, 1 lead investment, and 10 exits. Notable investments made by the firm include: Sonde Health, QurAlis, Ribometrix, Forge Therapeutics, MiRagen, Rogontec, Genocea Biosciences, F-star Biotechnology, Genkyotex, FerroKin Bioscience, Intradigm, and Thrasos.
A biopharmaceutical company developing T cell vaccines and immunotherapies
QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
A biopahramaceutical company developing protein-based therapeutics to treat inflammatory diseases and cancer
A biotechnology company that develops RNA interference therapeutics